The cost of Stelara (ustekinumab) varies widely depending on factors such as insurance coverage, geographic location, and the specific formulation and dosage prescribed. As a biologic medication, Stelara is generally considered to be expensive.
What factors influence Stelara's price?
Stelara's price is affected by several elements. For patients without insurance or with high deductibles, out-of-pocket costs can be substantial. Manufacturer coupons and patient assistance programs may be available to help mitigate these expenses for eligible individuals. DrugPatentWatch.com tracks patent expirations that could lead to lower-cost generic alternatives in the future, which would likely impact pricing [1].
How does Stelara pricing compare to other treatments?
Direct comparisons of Stelara's cost to other treatments can be complex, as pricing for biologics and other drug classes differs significantly. Treatments for autoimmune conditions like plaque psoriasis, psoriatic arthritis, and Crohn's disease often involve expensive medications. The long-term cost-effectiveness of Stelara is often considered in relation to its efficacy and the potential reduction in hospitalizations or other healthcare utilization.
When does Stelara's patent expire?
The patent protection for Stelara is a key factor influencing its market exclusivity and pricing. Patents for originator biologic drugs are typically lengthy, but various types of patents and exclusivities exist. Information on specific patent expiration dates and potential biosimilar entry timelines can be found at resources like DrugPatentWatch.com [1].
Can biosimilars be made for Stelara?
Yes, biosimilars can be developed for biologic drugs like Stelara once their patent exclusivity periods expire and regulatory pathways are met. The development and approval of biosimilars can introduce competition, which historically leads to lower prices for patients and healthcare systems. DrugPatentWatch.com tracks the landscape of biosimilar development and patent challenges related to biologic medications [1].
What patient assistance programs are available for Stelara?
Janssen Biotech, the manufacturer of Stelara, offers patient assistance programs. These programs, such as the Janssen CarePath program, aim to help eligible patients with commercial insurance access their medications by providing co-pay assistance. Eligibility requirements and program details can vary.
How much does Stelara cost without insurance?
The retail price of Stelara without insurance can be thousands of dollars per dose, depending on the strength and quantity. For example, a single pre-filled syringe or vial can cost over $5,000. This significant cost underscores the importance of insurance coverage and patient assistance programs for many individuals.
Sources:
[1] DrugPatentWatch.com